Summit Therapeutics Inc.

8-K Entered a material agreement Jul 23, 2026 10-Q Quarter ended 2026-06-30 Jul 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 23, 2026 8-K Other events Jul 22, 2026 8-K Shareholder vote results Jun 12, 2026 8-K Regulation FD disclosure Jun 11, 2026 8-K Other events Jun 3, 2026 8-K Other events Jun 1, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 23, 2026 8-K Other events Jan 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Other events Nov 7, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 22, 2025 10-Q Quarter ended 2025-09-30 Oct 20, 2025 8-K Results of operations (earnings release); Other events Oct 20, 2025 8-K Other events Sep 8, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Entered a material agreement Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Entered a material agreement Jun 20, 2025 8-K Shareholder vote results Jun 17, 2025 8-K Other events May 30, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 1, 2025 8-K Other events Apr 25, 2025 8-K Other events Apr 23, 2025 10-K Fiscal year ended 2024-12-31 Feb 24, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 24, 2025 8-K Director or officer change; Other events Jan 24, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 12, 2024 8-K Regulation FD disclosure; Other events Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2024 8-K Entered a material agreement; Director or officer change Jun 27, 2024